Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal

2 weeks ago 13
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal

Related

First Guaranty Bancshares Director Robert Walker Acquires $50.8k in Stock

First Guaranty Bancshares Director Robert Walker Acquires $5...

2 hours ago 0
Sprouts Farmers Market April 2025 slides: 1,000+ store target amid robust growth

Sprouts Farmers Market April 2025 slides: 1,000+ store targe...

2 hours ago 1
Qualcomm sees third-quarter revenue below estimates, shares drop 6%

Qualcomm sees third-quarter revenue below estimates, shares ...

2 hours ago 1
RIGHT SIDEBAR TOP AD

Trending

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

2 weeks ago 89
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

2 weeks ago 88
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

2 weeks ago 78
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

2 weeks ago 72
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

2 weeks ago 71
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved